rewirebio.iobenchmarks
Configuration

ClusPro BM5 Table1 antibody

Antibody-specific mode; Table1 does not explicitly label a masking condition. Do not infer masking from separate Figure3 experiments.

4 evaluations · 40 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Model Capabilities & Hardware Requirements

Deployment facts recorded for ClusPro BM5 Table1 antibody. Fields the record does not carry are marked not recorded.

ParametersNot recorded
Minimum VRAMNot recorded
Inference LatencyNot recorded
Context WindowNot recorded
AccessNot recorded
LicenseNot recorded

Evaluated Checkpoint: 2020 author configuration

Evaluations and results

4 evaluations · 40 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top10
Dataset subset: BM5 Bound antibody Table1 cohort
7 CAPRI acceptable targets (all targets)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; Good models Number
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top10
Dataset subset: BM5 Bound antibody Table1 cohort
0 CAPRI acceptable targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top10
Dataset subset: BM5 Bound antibody Table1 cohort
0 CAPRI high-quality targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top10
Dataset subset: BM5 Bound antibody Table1 cohort
0 CAPRI medium targets (difficult (flexible) targets; top 10 models; medium (**) as printed, overlap with high not stated)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; difficult column; medium_accuracy_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top10
Dataset subset: BM5 Bound antibody Table1 cohort
7 CAPRI acceptable targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top10
Dataset subset: BM5 Bound antibody Table1 cohort
2 CAPRI high-quality targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top10
Dataset subset: BM5 Bound antibody Table1 cohort
4 CAPRI medium targets (easy (rigid-body) targets; top 10 models; medium (**) as printed, overlap with high not stated)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; easy column; medium_accuracy_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top10
Dataset subset: BM5 Bound antibody Table1 cohort
N/A CAPRI acceptable targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; intermediate column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top10
Dataset subset: BM5 Bound antibody Table1 cohort
58.3% CAPRI top-10 success rate
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, first (top10) row; Good models %
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top30
Dataset subset: BM5 Bound antibody Table1 cohort
10 CAPRI acceptable targets (all targets)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top30

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; Good models Number
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top30
Dataset subset: BM5 Bound antibody Table1 cohort
0 CAPRI acceptable targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top30

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top30
Dataset subset: BM5 Bound antibody Table1 cohort
0 CAPRI high-quality targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top30

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top30
Dataset subset: BM5 Bound antibody Table1 cohort
0 CAPRI medium targets (difficult (flexible) targets; top 30 models; medium (**) as printed, overlap with high not stated)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top30

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; difficult column; medium_accuracy_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top30
Dataset subset: BM5 Bound antibody Table1 cohort
10 CAPRI acceptable targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top30

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top30
Dataset subset: BM5 Bound antibody Table1 cohort
3 CAPRI high-quality targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top30

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top30
Dataset subset: BM5 Bound antibody Table1 cohort
6 CAPRI medium targets (easy (rigid-body) targets; top 30 models; medium (**) as printed, overlap with high not stated)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top30

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; easy column; medium_accuracy_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top30
Dataset subset: BM5 Bound antibody Table1 cohort
N/A CAPRI acceptable targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top30

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; intermediate column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Bound antibody top30
Dataset subset: BM5 Bound antibody Table1 cohort
83.3% CAPRI top-30 success rate
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Bound antibody top30

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Bound antibody, second (top30) row; Good models %
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Unbound antibody top10
Dataset subset: BM5 Unbound antibody Table1 cohort
12 CAPRI acceptable targets (all targets)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Unbound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; Good models Number
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Unbound antibody top10
Dataset subset: BM5 Unbound antibody Table1 cohort
0 CAPRI acceptable targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Unbound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Unbound antibody top10
Dataset subset: BM5 Unbound antibody Table1 cohort
0 CAPRI high-quality targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Unbound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Unbound antibody top10
Dataset subset: BM5 Unbound antibody Table1 cohort
0 CAPRI medium targets (difficult (flexible) targets; top 10 models; medium (**) as printed, overlap with high not stated)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Unbound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; difficult column; medium_accuracy_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Unbound antibody top10
Dataset subset: BM5 Unbound antibody Table1 cohort
11 CAPRI acceptable targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Unbound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; acceptable_or_better_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Unbound antibody top10
Dataset subset: BM5 Unbound antibody Table1 cohort
0 CAPRI high-quality targets (by difficulty category)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Unbound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; high_accuracy_targets
Configuration: ClusPro BM5 Table1 antibodyProtocol: ClusPro BM5 Unbound antibody top10
Dataset subset: BM5 Unbound antibody Table1 cohort
6 CAPRI medium targets (easy (rigid-body) targets; top 10 models; medium (**) as printed, overlap with high not stated)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

ClusPro Unbound antibody top10

Not reported

Aggregation: Not reported

Performance and its limits in rigid body protein-protein docking · Table1 Unbound antibody, first (top10) row; easy column; medium_accuracy_targets

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Use this configuration

How it works, versions and access

Related profile: ClusPro rigid-body docking. This page retains the exact record and its evaluation context.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

1 evidence row matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Relationship: configuration of
ucc-docking-cluspro-bm5-2020-method
Individual claims
Performance and its limits in rigid body protein-protein docking

Original source ↗

Results and STAR Methods ClusPro Docking Server

Version: Structure 28(9):1071–1081.e3; 2020; PMC author manuscript NIHMS1608597
Retrieved: 2026-09-30T21:50:23.483497+00:00

source checked

["automated-source-review"] · 2026-09-30T21:50:23.483497+00:00

Audit details

Source transcription only; not execution, human scientific review or independent reproduction.

Field: links:configuration_of:ucc-docking-cluspro-bm5-2020-method

Claim: ucc-docking-cluspro-bm5-2020-claim-config-antibody

Source artifact SHA-256: 1c02bd7c53eb0e5d5c243b5e6da23168eb20bcc32ab970719666a5838fd58443

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ucc-docking-cluspro-bm5-2020-config-antibody.

Source locator: Results paragraph preceding Table1; STAR Methods ClusPro Docking Server

Related records

How to cite

ClusPro BM5 Table1 antibody. Rewire biological model benchmark database, release 2026-11-21-c8bea25e5abb. https://benchmarks.rewirebio.io/database/configuration/ucc-docking-cluspro-bm5-2020-config-antibody/

Release 2026-11-21-c8bea25e5abb. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.

The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence

Suggest a correction